About Agio Pharmaceuticals
Agio Pharmaceuticals is a Healthcare company based in Mumbai (India) founded in 1991. Pharmaceutical products for human and animal healthcare operations in India. The company has 343 employees. Its Indian entity Agio Pharmaceuticals Limited reported revenue of ₹288 Cr. Agio Pharmaceuticals offers products and services including Human Healthcare Products and Animal Healthcare Products. Its focus areas include Veterinary, Animal Healthcare, Animal Medicines and Pharmaceuticals.
Company details
AGIO Pharmaceuticals Limited is identified as a company that operates in the healthcare sector, with a focus on human and animal healthcare products. Information is presented on their corporate overview, vision, values, and quality policy, which are accessed through the website. Research and development activities are highlighted, along with accreditations and certificates that are maintained. The companys presence includes offices in Mumbai and a manufacturing unit in Pune, India, where products are developed and distributed. Contact details and pharmacovigilance information are also provided for inquiries, ensuring operational transparency is upheld.
- Headquarters Mumbai, India
- Employees 343
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Legal Name Agio Pharmaceuticals Limited
- Date of Incorporation 24 Jan, 1992
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹288 Cr
FY 2025 · +29% YoY
- Net Profit₹31.33 Cr
FY 2025 · 11% margin
- EBITDA₹75.26 Cr
FY 2025 · 26% margin
- Employee Count343
Associated legal entities of Agio Pharmaceuticals
Agio Pharmaceuticals operates through Agio Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Agio Pharmaceuticals Limited CIN U24239MH1992PLC065031 | Active | 24 Jan 1992 | Mumbai, Maharashtra | ₹288 Cr | 343 | 3 | View details |
Products & Services of Agio Pharmaceuticals
Agio Pharmaceuticals offers a comprehensive portfolio of products and services, including Human Healthcare Products and Animal Healthcare Products.
Human healthcare products are manufactured and distributed for various health needs, as referenced in the company's downloadable resources.
Animal healthcare products are provided for veterinary applications, based on the information available in the company's product sections.
Board of directors of Agio Pharmaceuticals Limited (Agio Pharmaceuticals)
Agio Pharmaceuticals Limited is the primary company behind Agio Pharmaceuticals. The board of Agio Pharmaceuticals Limited currently have 3 directors; the longest-serving is Madhusudan Govindprasad Ruia, appointed in 1992. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Madhusudan Govindprasad Ruia DIN 00018971 | Managing Director | 24 Jan 1992 | 34 yrs 8 mo | Agio Pharmaceuticals Limited |
| Raghav Sanjay Ruia DIN 08576327 | Whole-time director | 04 Oct 2019 | 7 yrs | Agio Pharmaceuticals Limited |
| Mahendra Kumar Kumawat DIN 08873555 | Whole-time director | 09 Sep 2020 | 6 yrs 1 mo | Agio Pharmaceuticals Limited |
People of Agio Pharmaceuticals
3 people are tracked at Agio Pharmaceuticals (2 in leadership, 1 in team); the tracked headcount is 343.
| Name | Role | Group |
|---|---|---|
Brian Goff | CEO | Leadership |
Viraj Kulkarni | Business Head Overseas Operations | Leadership |
Sanjay Roy | Business Development Manager | Team |
Complete people profiles for Agio Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Agio Pharmaceuticals
Figures of Agio Pharmaceuticals Limited, the primary company behind Agio Pharmaceuticals, for FY 2025. Revenue was ₹288 Cr (+29% year on year). Net profit was ₹31.33 Cr (11% margin). EBITDA was ₹75.26 Cr (26% margin). Revenue has grown at a compounded annual rate of +38% over three years and +19% over five years.
- ₹288 CrRevenue · FY 2025 · +29% YoY
- ₹31.33 CrNet profit · 11% margin
- ₹75.26 CrEBITDA · 26% margin
- ₹5.18 CrPaid-up capital
- 343Employees (provident fund records)
- +38%Revenue CAGR, 3 years
- +19%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Agio Pharmaceuticals Limited are on its company page.
Detailed financial statements for Agio Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Agio Pharmaceuticals
The website of Agio Pharmaceuticals (agio-pharma.com) receives about 1.4K visits a month and ranks #10,172,807 among all websites worldwide, #7,855 in Biotechnology and Pharmaceuticals.
- Monthly visits1.4K
▼ 14.3% vs previous month
- Global rank#10,172,807
among all websites
- Category rank#7,855
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit1.5
- Average visit10 sec
- DevicesDesktop 38% · Mobile 62%
Websites whose visitors overlap most with Agio Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cadilapharma.com | 100% | 18.5K | #1,452,788 | View details | |
| actavis.com | 100% | View details | |||
eyeforpharma.com | eyeforpharma.com | 100% | – | ||
pharmexcil.com | pharmexcil.com | 99% | #794,041 | – | |
| pharmatimes.com | 99% | #859,223 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Agio Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Agio Pharmaceuticals
Agio Pharmaceuticals was founded in 1991.
Agio Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Agio Pharmaceuticals has 343 employees.
The primary company behind Agio Pharmaceuticals, Agio Pharmaceuticals Limited, reported revenue of ₹288 Cr for FY 2025, up 29% year on year.
AGIO Pharmaceuticals Limited is identified as a company that operates in the healthcare sector, with a focus on human and animal healthcare products. Information is presented on their corporate overview, vision, values, and quality policy, which are accessed through the website. Research and development activities are highlighted, along with accreditations and certificates that are maintained. The companys presence includes offices in Mumbai and a manufacturing unit in Pune, India, where products are developed and distributed. Contact details and pharmacovigilance information are also provided for inquiries, ensuring operational transparency is upheld.
Agio Pharmaceuticals offers Human Healthcare Products and Animal Healthcare Products.
Agio Pharmaceuticals operates through Agio Pharmaceuticals Limited.
The legal entities of Agio Pharmaceuticals currently have 3 directors, including Mahendra Kumar Kumawat, Raghav Sanjay Ruia, Madhusudan Govindprasad Ruia.